Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) Models
André Wieringa, Alan Abdulla(Erasmus MC), Birgit C. P. Koch(University Medical Center Groningen), Tim M. J. Ewoldt(Erasmus MC), Matthias Gijsen(Universitair Ziekenhuis Leuven), Reinier M. van Hest(Amsterdam University Medical Centers), Nestor Parolya, Henrik Endeman(Erasmus MC), Isabel Spriet(KU Leuven), Chantal J. A. R. Kats(Medisch Centrum Haaglanden), Ravish N. Gangapersad(Erasmus MC), Jasper J. Haringman(Isala)
Cited by 7
Related Papers
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2004|464
Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study
|The Lancet Respiratory Medicine|2020|306
A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis
|Arthritis & Rheumatism|2006|255
Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis
|Annals of the Rheumatic Diseases|2003|220
Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis
|Arthritis & Rheumatism|2004|155